Container and method for facilitating disposal of unused pharmaceutical product

• US 9,005,098 B2
• Filed: 06/24/2013
• Issued: 04/14/2015
• Est. Priority Date: 02/01/2010
• Status: Active Grant

• Current Assignee: SpecGx LLC (Mallinckrodt plc)
• Original Assignee: Mallinckrodt LLC (Mallinckrodt plc)
• Inventors: Ziemba, Robert J.
• Primary Examiner(s): KRECK, JOHN J
• Application Number:
  US13/925,680
• Publication Number:
  US 20130283734A1
• Time in Patent Office: 659 Days
• Field of Search: 588/249, 588/249.5
• US Class Current: 588/252
• CPC Class Codes: A61J 1/00 Containers specially adapted for medical or pharmaceutical purposes capsules or the like for oral use A61J3/07; specially adapted for surgical or diagnostic appliances or instruments A61B50/30; containers for radioactive substances G21F5/00
• CPC Class Codes: A61J 1/03 for pills or tablets containers for pills or tablets with special dispensing means therefor B65D83/04
• CPC Class Codes: A61J 1/035 Blister-type containers blisters in general B65D75/36
• CPC Class Codes: B65B 3/04 Methods of, or means for, filling the material into the containers or receptacles
• CPC Class Codes: B65B 53/02 by heat

Abstract

Containers and methods for disposing unused pharmaceutical product are disclosed. Each container (100, 200, 300) may include a container body (104, 204, 304) with an internal chamber (116, 216, 316) for storing pharmaceutical product, along with a cover (124, 224, 324) for selectively limiting access to the chamber (116, 216, 316). An encapsulation component (128, 228, 328) may be selectively disposable within the chamber (116, 216, 316), and may be operable to encapsulate the pharmaceutical product within the container (100, 200, 300). For instance, the encapsulation component (128, 228, 328) may melt and/or flow into contact with the pharmaceutical product and thereafter solidify to encapsulate the pharmaceutical product. The encapsulation component (128, 228, 328) may melt and thereafter solidify between the cover (124, 224, 324) and shell (104, 204, 304) to limit removal of the cover (124, 224, 324) from the shell (104, 204, 304).

Claims

1. A method of managing pharmaceutical product use, comprising the steps of:

opening a pharmaceutical product container comprising a first melting temperature, wherein said pharmaceutical product container comprises a container body and an access member, wherein said opening step comprises moving said access member to an open position to provide access to a chamber within said container body, wherein a plurality of individual pharmaceutical product components are stored within said chamber, wherein each said pharmaceutical product component is an individual dose, and wherein a heat-activated encapsulation component is also disposed within said chamber and has a second melting temperature that is lower than said first melting temperature of said pharmaceutical product container;

removing a first said pharmaceutical product component from said chamber of said pharmaceutical product container after said opening step;

closing said pharmaceutical product container after said removing step, wherein said closing step comprises moving said access member to a closed position to close off said chamber;

heating said pharmaceutical product container after said closing step, wherein said heating step comprises heating said heat-activated encapsulation component to a temperature that is above said second melting temperature of said heat-activated encapsulation component but that is lower than said first melting temperature of said pharmaceutical product container; and

encapsulating said pharmaceutical product components remaining within said chamber of said pharmaceutical product container after said closing step and in response to said heating step.

2. The method of claim 1, wherein said closing step comprises interlocking said access member with said container body.

3. The method of claim 1, wherein said closing step comprises detachably securing said access member to said container body.

4. The method of claim 3, wherein said detachably securing step further comprises threading said access member onto said container body.

5. The method of claim 1, wherein said encapsulating step comprises at least one of bonding said access member to said container body with encapsulation material from a melting of said heat-activated encapsulation component by said heating step, and contacting said pharmaceutical product components remaining in said pharmaceutical product container with said encapsulation material.

6. The method of claim 1, wherein said encapsulating step comprises both bonding said access member to said container body with encapsulation material from a melting of said heat-activated encapsulation component by said heating step,and contacting said pharmaceutical product components remaining in said pharmaceutical product container with said encapsulation material.

7. The method of claim 1, wherein said encapsulating step further comprises allowing encapsulation material, from a melting of said heat-activated encapsulation component by said heating step, to solidify around said pharmaceutical product components remaining within said pharmaceutical product container.

8. The method of claim 1, wherein said encapsulating step further comprises allowing encapsulation material, from a melting of said heat-activated encapsulation component by said heating step, to solidify between said container body and said access member.

9. The method of claim 1, wherein said heat-activated encapsulation component is separately incorporated on said access member.

10. The method of claim 1, further comprising:

allowing said pharmaceutical product container to cool after said heating step.

11. The method of claim 1, further comprising:

disposing of said pharmaceutical product container, along with said pharmaceutical product components remaining within said pharmaceutical product container, after said heating step.

12. The method of claim 1, wherein said heating step comprises using a microwave oven.

13. The method of claim 1, wherein said encapsulating step comprises fixedly sealing said pharmaceutical product container.

14. The method of claim 1, wherein each said pharmaceutical product Component is selected from the group consisting of a pill, a capsule, a caplet, a tablet, and a patch.

15. A method of managing pharmaceutical product use, comprising the steps of:

opening a pharmaceutical product container comprising pharmaceutical product, wherein each said pharmaceutical product is selected from the group consisting of a pill, a capsule, a caplet, a tablet, and a patch;

removing a first of said pharmaceutical product from said pharmaceutical product container after said opening step;

closing said pharmaceutical product container after said removing step;

heating said pharmaceutical product container after said closing step; and

encapsulating said pharmaceutical product remaining within said pharmaceutical product container after said closing step and in response to said heating step.

16. The method of claim 15, wherein said pharmaceutical product container comprises a container body and an access member, wherein said opening step comprises moving said access member to an open position, and wherein said closing step comprises moving said access member to a closed position.

17. The method of claim 16, further comprising the step of:

activating a heat-activated encapsulation material disposed inside said pharmaceutical product container in response to said heating step.

18. The method of claim 17, wherein said encapsulating step comprises at least one of bonding said access member to said container body with said heat-activated encapsulation material, and contacting said pharmaceutical product remaining in said container with said heat-activated encapsulation material.

19. The method of claim 15, further comprising:

disposing of said pharmaceutical product container, along with said pharmaceutical product remaining within said pharmaceutical product container, after said heating step.

20. The method of claim 15, wherein said heating step comprises not heating said pharmaceutical product container above a melting temperature of said pharmaceutical product container.